The Department of Oncology would like to congratulate Dr. Frank Wuest, Division of Oncologic Imaging, and Dr. John Lewis, Division of Experimental Oncology, for their recent success in the 2017 Kaye Fund competition. These two innovative and translational grant proposals relate to better methods to diagnose prostate cancer and should lead to improvements in following response to therapy and/or identify those patients who are likely to recur or progress under current management. Only 7 of 23 full applications to the Kaye Fund Competition were successful and the Department of Oncology received 2 of these 7 awards. Well done, Frank and John!"
David D. Eisenstat, MD, MA, FRCPC
Chair, Department of Oncology, University of Alberta
Muriel & Ada Hole Kids with Cancer Society Chair in Pediatric Oncology
Professor, Departments of Oncology, Medical Genetics and Pediatrics
Through his naming gift to the University Hospital Foundation, Donald Kaye has transformed years of hard work, prudent decision-making and wise investing into one of the largest donations in the history of Canadian healthcare philanthropy. And in doing so, Mr. Kaye is advancing patient care and medical research in a way that is both intently focused, and broadly based.
Awardee: Dr. Frank Wuest
Project Title: Novel Radiolabeled PSMA Inhibitors for Clinical PET Imaging of Prostate Cancer
Project Focus: The introduction of innovative molecular imaging technology into clinics aimed at earlier diagnosis, more accurate disease staging, and better measurement of therapy responses for prostate cancer patients.
Awardee: Dr. John Lewis
Project Title:Improving the Management of Prostate Cancer Using Advanced Biofluid Diagnostics
Project Focus: The development of an improved test aimed at reducing unnecessary biopsies and over-diagnosis of indolent prostate disease, and to enable appropriate early diagnosis and the opportunity for curative treatment.